Chronic myeloid leukemia : (Record no. 35705)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01736nam a22002777a 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OSt |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250219174641.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 250219b |||||||| |||| 00| 0 hin d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781853178900 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NISER LIBRARY |
Language of cataloging | eng |
Transcribing agency | NISER LIBRARY |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | English |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.155.392 |
Item number | CAR-C |
245 ## - TITLE STATEMENT | |
Title | Chronic myeloid leukemia : |
Remainder of title | biology and treatment |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Place of publication, distribution, etc. | London : |
Name of publisher, distributor, etc. | Martin Dunitz Ltd, |
Date of publication, distribution, etc. | 2001. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | xv, 528 pages |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc | Includes bibliographical references and index. |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Tremendous advances have been made in our understanding of the molecular mechanisms involved in human disease, and it can be argued that in this context chronic myeloid leukaemia is perhaps the best understood of all human malignancies. This text, from a world-renowned team of experts in CML, examines these advances and the implications they have for the management of this disease. Topics covered include the molecular and cellular biology of CML, conventional chemotherapy and interferon therapy, and recent developments in allografting and autografting. The book concludes with an overview of novel target-directed therapies, particularly the recent results with the tyrosine kinase inhibitor, STI571. This comprehensive text will be essential reading for all haemato-oncologists involved in this field. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Acute myeloid leukemia |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Carella, Angelo M. |
Relator term | editor |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Daley, George Q. |
Relator term | editor |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Eaves, Connie J. |
Relator term | editor |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Goldman, John M. |
Relator term | editor |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hehlmann, Rüdiger |
Relator term | editor |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
Materials specified | Reviews |
Uniform Resource Identifier | <a href="https://www.goodreads.com/book/show/7256258-chronic-myeloid-leukemia?ref=nav_sb_ss_1_13#CommunityReviews">https://www.goodreads.com/book/show/7256258-chronic-myeloid-leukemia?ref=nav_sb_ss_1_13#CommunityReviews</a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Universal Decimal Classification |
Koha item type | Book |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Source of acquisition | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Universal Decimal Classification | NISER LIBRARY | NISER LIBRARY | 13/02/2025 | Order No. NISER/LIB/BK/PO/2024-25/38, Dt. 16/01/2025; CBS Publishers & Distributors Pvt. Ltd.; Invoice No. COR/IN/25/9527, Dt. 20/01/2025 | 616.155.392 CAR-C | 25718 | 19/02/2025 | 19/02/2025 | Book |